Form 4: Edwards Lifesciences Officer Sells, Gifts Shares

Donald E. Bobo Jr., CVP of Strategy/Corp Development at Edwards Lifesciences, reported sales and a gift of common stock totaling 18,486.1175 shares on December 12, 2025.

Summary

• Donald E. Bobo Jr., who serves as CVP, Strategy/Corp Development and Director at Edwards Lifesciences Corp (EW), reported transactions involving the company's common stock.
• On December 12, 2025, Mr. Bobo sold 5,486.1175 shares of common stock at a price of $83.79 per share.
• An additional 5,900 shares of common stock were sold on the same date at a price of $83.74 per share.
• Mr. Bobo also gifted 7,100 shares of common stock on December 12, 2025.
• These transactions were executed pursuant to a Rule 10b5-1(c) plan.
• Following these reported transactions, Mr. Bobo directly beneficially owns 31,870.2532 shares of common stock.
• Indirect beneficial ownership includes 38,817.6991 shares held in a 401(k) plan and 135,152 shares held by a Trust.

Sentiment

Score: 5

Explanation: This Form 4 filing is a factual report of insider transactions and does not contain information that would inherently indicate positive or negative sentiment regarding the company's operational or financial performance. The transactions were made under a Rule 10b5-1 plan, which suggests pre-scheduled activity rather than a reaction to immediate news.

Future Outlook

This Form 4 filing reports past and scheduled insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a standard disclosure of an insider's equity transactions and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: The sale and gift of shares by an officer may be noted by investors, but given the transactions are under a 10b5-1 plan and represent a relatively small portion of the company's total outstanding shares, the direct impact on shareholder value is likely minimal.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Keywords

Edwards Lifesciences, EW, Insider Transaction, Form 4, Stock Sale, Stock Gift, Officer Transaction, Donald E. Bobo Jr., 10b5-1 Plan, Corporate Development, Strategy